The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Liver Cancer Therapeutics-Global Market Insights and Sales Trends 2024
Synopsis
Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.
The global Liver Cancer Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Liver Cancer Therapeutics in various end use industries. The expanding demands from the Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma and Other, are propelling Liver Cancer Therapeutics market. Targeted Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liver Cancer Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Liver Cancer Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Liver Cancer Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liver Cancer Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Liver Cancer Therapeutics covered in this report include ArQule, Bayer, Bristol-Myers Squibb, Celsion, Eisai, Exelixis, Roche, Merck and Pfizer, etc.
The global Liver Cancer Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ArQule
Bayer
Bristol-Myers Squibb
Celsion
Eisai
Exelixis
Roche
Merck
Pfizer
IntegraGen
Global Liver Cancer Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liver Cancer Therapeutics market, Segment by Type:
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Other
Global Liver Cancer Therapeutics market, by Application
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Liver Cancer Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Liver cancer, also known as hepatic cancer and primary hepatic cancer, is cancer that starts in the liver. Cancer which has spread from elsewhere to the liver, known as liver metastasis, is more common than that which starts in the liver. Symptoms of liver cancer may include a lump or pain in the right side below the rib cage, swelling of the abdomen, yellowish skin, easy bruising, weight loss, and weakness. The treatment of liver cancer patients is mainly determined by the organ involved, the tumor spread, the patient's general condition and age.
The global Liver Cancer Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Liver Cancer Therapeutics in various end use industries. The expanding demands from the Hepatocellular Carcinoma, Cholangio Carcinoma, Hepatoblastoma and Other, are propelling Liver Cancer Therapeutics market. Targeted Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Radiation Therapy segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Liver Cancer Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Liver Cancer Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Liver Cancer Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Liver Cancer Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Liver Cancer Therapeutics covered in this report include ArQule, Bayer, Bristol-Myers Squibb, Celsion, Eisai, Exelixis, Roche, Merck and Pfizer, etc.
The global Liver Cancer Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
ArQule
Bayer
Bristol-Myers Squibb
Celsion
Eisai
Exelixis
Roche
Merck
Pfizer
IntegraGen
Global Liver Cancer Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liver Cancer Therapeutics market, Segment by Type:
Targeted Therapy
Radiation Therapy
Immunotherapy
Chemotherapy
Other
Global Liver Cancer Therapeutics market, by Application
Hepatocellular Carcinoma
Cholangio Carcinoma
Hepatoblastoma
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Liver Cancer Therapeutics companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Liver Cancer Therapeutics
1.1 Liver Cancer Therapeutics Market Overview
1.1.1 Liver Cancer Therapeutics Product Scope
1.1.2 Liver Cancer Therapeutics Market Status and Outlook
1.2 Global Liver Cancer Therapeutics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Liver Cancer Therapeutics Market Size by Region (2018-2029)
1.4 Global Liver Cancer Therapeutics Historic Market Size by Region (2018-2023)
1.5 Global Liver Cancer Therapeutics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Liver Cancer Therapeutics Market Size (2018-2029)
1.6.1 North America Liver Cancer Therapeutics Market Size (2018-2029)
1.6.2 Europe Liver Cancer Therapeutics Market Size (2018-2029)
1.6.3 Asia-Pacific Liver Cancer Therapeutics Market Size (2018-2029)
1.6.4 Latin America Liver Cancer Therapeutics Market Size (2018-2029)
1.6.5 Middle East & Africa Liver Cancer Therapeutics Market Size (2018-2029)
2 Liver Cancer Therapeutics Market by Type
2.1 Introduction
2.1.1 Targeted Therapy
2.1.2 Radiation Therapy
2.1.3 Immunotherapy
2.1.4 Chemotherapy
2.1.5 Other
2.2 Global Liver Cancer Therapeutics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Liver Cancer Therapeutics Historic Market Size by Type (2018-2023)
2.2.2 Global Liver Cancer Therapeutics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Liver Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Liver Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Liver Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Liver Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Liver Cancer Therapeutics Revenue Breakdown by Type (2018-2029)
3 Liver Cancer Therapeutics Market Overview by Application
3.1 Introduction
3.1.1 Hepatocellular Carcinoma
3.1.2 Cholangio Carcinoma
3.1.3 Hepatoblastoma
3.1.4 Other
3.2 Global Liver Cancer Therapeutics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Liver Cancer Therapeutics Historic Market Size by Application (2018-2023)
3.2.2 Global Liver Cancer Therapeutics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Liver Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Liver Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Liver Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Liver Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Liver Cancer Therapeutics Revenue Breakdown by Application (2018-2029)
4 Liver Cancer Therapeutics Competition Analysis by Players
4.1 Global Liver Cancer Therapeutics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Liver Cancer Therapeutics as of 2022)
4.3 Date of Key Players Enter into Liver Cancer Therapeutics Market
4.4 Global Top Players Liver Cancer Therapeutics Headquarters and Area Served
4.5 Key Players Liver Cancer Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Liver Cancer Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 ArQule
5.1.1 ArQule Profile
5.1.2 ArQule Main Business
5.1.3 ArQule Liver Cancer Therapeutics Products, Services and Solutions
5.1.4 ArQule Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.1.5 ArQule Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Liver Cancer Therapeutics Products, Services and Solutions
5.2.4 Bayer Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Bristol-Myers Squibb
5.3.1 Bristol-Myers Squibb Profile
5.3.2 Bristol-Myers Squibb Main Business
5.3.3 Bristol-Myers Squibb Liver Cancer Therapeutics Products, Services and Solutions
5.3.4 Bristol-Myers Squibb Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.3.5 Celsion Recent Developments
5.4 Celsion
5.4.1 Celsion Profile
5.4.2 Celsion Main Business
5.4.3 Celsion Liver Cancer Therapeutics Products, Services and Solutions
5.4.4 Celsion Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.4.5 Celsion Recent Developments
5.5 Eisai
5.5.1 Eisai Profile
5.5.2 Eisai Main Business
5.5.3 Eisai Liver Cancer Therapeutics Products, Services and Solutions
5.5.4 Eisai Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.5.5 Eisai Recent Developments
5.6 Exelixis
5.6.1 Exelixis Profile
5.6.2 Exelixis Main Business
5.6.3 Exelixis Liver Cancer Therapeutics Products, Services and Solutions
5.6.4 Exelixis Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.6.5 Exelixis Recent Developments
5.7 Roche
5.7.1 Roche Profile
5.7.2 Roche Main Business
5.7.3 Roche Liver Cancer Therapeutics Products, Services and Solutions
5.7.4 Roche Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.7.5 Roche Recent Developments
5.8 Merck
5.8.1 Merck Profile
5.8.2 Merck Main Business
5.8.3 Merck Liver Cancer Therapeutics Products, Services and Solutions
5.8.4 Merck Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.8.5 Merck Recent Developments
5.9 Pfizer
5.9.1 Pfizer Profile
5.9.2 Pfizer Main Business
5.9.3 Pfizer Liver Cancer Therapeutics Products, Services and Solutions
5.9.4 Pfizer Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.9.5 Pfizer Recent Developments
5.10 IntegraGen
5.10.1 IntegraGen Profile
5.10.2 IntegraGen Main Business
5.10.3 IntegraGen Liver Cancer Therapeutics Products, Services and Solutions
5.10.4 IntegraGen Liver Cancer Therapeutics Revenue (US$ Million) & (2018-2023)
5.10.5 IntegraGen Recent Developments
6 North America
6.1 North America Liver Cancer Therapeutics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Liver Cancer Therapeutics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Liver Cancer Therapeutics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Liver Cancer Therapeutics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Liver Cancer Therapeutics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Liver Cancer Therapeutics Market Dynamics
11.1 Liver Cancer Therapeutics Industry Trends
11.2 Liver Cancer Therapeutics Market Drivers
11.3 Liver Cancer Therapeutics Market Challenges
11.4 Liver Cancer Therapeutics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
